It was this theme, the importance of equity in digital health, that I spoke about at the Cambridge Wearable Innovation Forum ...

The information held within our genes and how it can be used to improve individual health, continues to generate excitement amongst researchers, health professionals and policymakers. The potential to ...

Advances in clinical genomics have been enabled by short-read sequencing (SRS) technologies, where the DNA is broken into pieces up to 300 base pairs long. While these technologies have many ...

Citizen generated data (CGD) is a collective term for the data generated by people outside health systems. It can provide insights into health and wellbeing which could contribute to prediction and ...

Genomic technologies have the potential to transform the management of infectious diseases. In Pathogen Genomics Into Practice we set out a roadmap to converting the power of this exciting new ...

Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...

In Artificial intelligence for genomic medicine we examine the intersection between AI and genomics, the drivers behind the recent rise of AI techniques for genomics and outline existing and emerging ...

Opinions differ as to the value of genetic information in the form of polygenic scores and the usefulness of polygenic score analysis as part of routine healthcare – clinical utility. Views on ...

Continued improvements in computing power and techniques means that health services are beginning to experience the benefits that machine learning has to offer. From supporting healthcare ...

The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...

Cancer incidence is increasing worldwide and in the UK it is estimated that 1 in 2 people born after 1960 will be diagnosed with some form of cancer in their lifetime. New tests that analyse ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...